ERBB2 and invasive carcinoma: HER2 mutation has been observed in only 3–6% of gallbladder carcinomas, while HER2 amplification has been reported in 5–10% of gallbladder carcinomas and was also described in 4% of HGD of the gallbladder with associated invasive carcinoma [11, 20–22].